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Abstract
Human placenta is a fetal-derived tissue that offers a unique sample of epigenetic and environmental exposures present
in utero. In the MARBLES prospective pregnancy study of high-risk younger siblings of children with autism spectrum
disorder (ASD), pregnancy and environmental factors collected by maternal interviews were examined as predictors of
placental DNA methylation, including partially methylated domains (PMDs), an embryonic feature of the placental methyl-
ome. DNA methylation data from MethylC-seq analysis of 47 placentas of children clinically diagnosed at 3 years with
ASD or typical development using standardized assessments were examined in relation to: child’s gestational age, birth-
weight, and diagnosis; maternal pre-pregnancy body mass index, smoking, education, parity, height, prenatal vitamin and
folate intake; home ownership; pesticides professionally applied to lawns or gardens or inside homes, pet flea/tick
pouches, collars, or soaps/shampoos used in the 3 months prior to or during pregnancy. Sequencing run, order, and cover-
age, and child race and sex were considered as potential confounders. Akaike information criterion was used to select the
most parsimonious among candidate models. Final prediction models used sandwich estimators to produce
homoscadisticity-robust estimates of the 95% confidence interval (CI) and P-values controlled the false discovery rate at
5%. The strongest, most robust associations were between pesticides professionally applied outside the home and
higher average methylation over PMDs [0.45 (95% CI 0.17, 0.72), P¼0.03] and a reduced proportion of the genome in
PMDs [0.42 (95% CI0.67 to0.17), P¼0.03]. Pesticide exposures could alter placental DNA methylation more than other
factors.
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Introduction
Autism spectrum disorder (ASD), a neurodevelopmental disor-
der characterized by impairments in social behavior and com-
munication, as well as restrictive and repetitive interests and
behaviors, currently affects an estimated 1 in 68 children in the
USA [1]. Emerging evidence suggests that ASDs and other neu-
rodevelopmental disorders arise from complex gene–environ-
ment interactions [2–6]. Although several environmental
risk factors for ASD have been identified, including prenatal air
pollution and pesticide exposure [7], and evidence for gene–
environment interactions is emerging [8, 9], additional environ-
mental factors are likely to influence susceptibility to ASD and
the mechanisms by which environmental factors interact with
genetic factors to determine individual risk remain critical gaps
in our understanding of ASD etiologies.
High-risk sibling study designs can aid the identification of
factors that contribute to increased risk for ASD in highly sus-
ceptible populations and offer a feasible prospective design that
can evaluate mechanistic markers. The prospective MARBLES
(Markers of Autism Risk in Babies: Learning Early Signs) study
recruits mothers of at least one child diagnosed with ASD who
are either planning or are pregnant with another child, in order
to understand what influences the outcome of the younger
high-risk sibling and to identify early markers of ASD. Given the
family history of ASD, with shared environmental and genetic
factors, the sibling is at higher risk for developing ASD and other
adverse neurodevelopmental outcomes than children from the
general population. Younger high-risk siblings are affected with
ASD at rates of nearly one in five (19%) [10], with significant dif-
ferences in familial recurrence between males (27%) versus
females (10%) [11]. Another 21% of these high-risk younger sib-
lings are affected with other aberrant neurodevelopmental out-
comes, including attention problems or language delays, or
broader autism phenotype, leaving about 60% with typical
development (TD) [10].
Epidemiologic evidence suggests that periconception and in
utero periods are the most vulnerable to environmental factors
influencing ASD risk [7, 12–16]. This study leverages the
MARBLES population with increased genetic susceptibility to
ASD and other neurodevelopmental disorders to evaluate which
gestational factors most influence global placental methylation
levels as a potential mechanistic biomarker.
DNA methylation marks could be ideal biomarkers at the
interface of ASD genetic and environmental risk factors [17].
Placenta is an accessible tissue with distinctive global and site-
specific DNA methylation patterns compared with somatic tis-
sues. Unlike the embryoblast, the trophoblast-derived placenta
does not undergo extensive re-methylation following the wave
of post-fertilization de-methylation, and, thereby, maintains a
genome-wide hypomethylated state [18,19]). Throughout preg-
nancy, the human placenta maintains a bimodal DNA methyla-
tion pattern characterized by interspersed partially methylated
domains (PMDs) and highly methylated domains (HMDs) that
are detectable in both sequencing and array-based platforms
[20]. PMDs are relatively large (over 100 kb) regions that span
transcriptionally repressed gene loci enriched for synaptic and
ASD candidate genes, together making up 40% of the placental
genome [20, 21]). We hypothesized that the percent methylation
levels within PMDs, which tend to be more variable than HMDs
[20], and are distinct to placenta and pre-implantation embryos
[21], might be sensitive as markers of early environmental expo-
sures relevant to brain development.
Previous studies have demonstrated that placenta DNA
methylation can provide specific signatures to early environ-
mental exposures. Altered placental global or site-specific DNA
methylation have been associated with exposures to: maternal
cigarette smoking [22, 23]), bisphenol A [24], air pollution [25],
and phthalates [26]. However, no study has yet investigated pla-
cental DNA methylation in relation to environmental contami-
nants using the unbiased whole genome bisulfite sequencing
MethylC-seq approach which includes the analysis of all
uniquely alignable CpGs in the genome.
To determine if common environmental exposures were
associated with individual variation in placental DNA methyla-
tion, demographic, pregnancy, and exposure data from ques-
tionnaires given to MARBLES mothers were examined for
associations by multivariate linear regression analysis with
average PMD and HMD methylation levels, and the percentage
of the genome within PMDs.
Results
Figure 1 demonstrates the observation of bimodal global DNA
methylation patterns characterized by the presence of HMDs
and PMDs for MARBLES placental samples, similar to the three
placental samples sequenced previously [21]. In this study pop-
ulation, mean average PMD methylation was 46.5% (SD¼ 2.6%)
and mean average HMD methylation was 75.4% (SD¼ 0.9%), and
the overall proportion of the genome in PMDs (with methyl-
ation<60%) was 43.7% (SD¼ 2.5%). Given that global genome-
wide methylation patterns were very similar between placenta
samples from 24 ASD and 23 typically developing (TD) children,
primary analyses were conducted of the association between
pregnancy and environmental exposures for all 47 placentas
combined, though differential associations by ASD status were
also considered. All results were similar when ASD status was
added to the model to adjust for case status (Table S1), likely
because ASD was not a significant predictor of HMD or PMD
average methylation or the proportion of the genome as PMD.
Also, we found that individuals with higher or lower methyla-
tion in HMDs/PMDs on one chromosome also tended to have
similar higher or lower methylation in HMDs/PMDs on the other
chromosomes. For this reason, exposures were examined in
relation to average methylation over all PMDs and HMDs. Since
a significant correlation between average PMD and average
HMD methylation levels was observed within individuals, PMD
analyses were conducted with and without adjustments for
HMD, and vice versa. In previous analyses, sequencing run,
order, and coverage, as well as child race/ethnicity and child sex
were not significantly associated with PMD or HMD methyla-
tion, but were included here for consideration in multivariate
models.
Predictors of PMDMethylation
In bivariate analyses, maternal smoking history and professio-
nally applied lawn and garden pesticides before or during
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pregnancy were associated with higher placental PMD methyla-
tion (Table 1), there was a trend for higher PMD methylation in
mothers with MTFHR 677 CT or TT genotypes, and a trend for
lower PMD methylation in those exposed before or during preg-
nancy to flea and tick pouches used on pets. In analyses adjust-
ing for HMD methylation, use of pet flea and tick pouches or
any pet pesticides, and food folate in the second half of preg-
nancy were significantly associated with lower placental PMD
methylation; there were trends towards associations with
higher placental PMD methylation observed for mothers who
ever smoked cigarettes. None of the other exposures examined
were significantly associated with PMD methylation (Table 1).
In multivariate models selected based on the lowest AIC,
mothers who reported pre-pregnancy or pregnancy exposure to
any professionally applied lawn and garden pesticides (typically
sprays and foggers) had higher placental DNA methylation
across PMDs (Table 2). Lower placental DNA methylation across
PMDs was observed in placentas of mothers who reported using
pet pesticides including flea/tick pouches applied to pet, flea/
tick collars, or flea/tick pet soaps/shampoos before or during
pregnancy and who had non-white children (Table 2). After
false discovery rate (FDR) correction, non-white race was no
longer a statistically significant predictor, and pet pesticides
were associated with a trend. In the subset with genotype data
available, maternal MTHFR 677 CT/TT genotype was associated
with higher PMD methylation after adjustment for other factors
selected by best model fit (Table 2), and after adjustment for
HMD methylation (P¼ 0.01), but was not significant after FDR
correction (Table 2). In the HMD-adjusted model, only flea/tick
pouches applied to pets before or during pregnancy remained
statistically significant after FDR correction (Table 2). In post-
hoc analyses, pet ownership was examined as a confounder of
the association between pet pesticides and PMD methylation,
and pet pesticides were assessed only within pet owners.
The association between pet pesticides was attenuated when
pet ownership was included in the model and in analyses
restricted to pet owners, but there remained a trend towards an
association between flea pouches and lower PMD methylation
prior to FDR correction (Table S2); results were similar when
adjusted for HMD methylation.
When predictors of PMD methylation were examined sepa-
rately for ASD and TD children, professionally sprayed lawn and
garden pesticides were a strong predictor in TD children,
whereas maternal graduate education and flea pouches tended
to be associated in both ASD and TD children (Tables S3).
However, in TD children, pet ownership was also a strong pre-
dictor of lower PMD methylation, and when it was included in
model selection and in analyses restricted to pet owners, flea
pouches and pet pesticides were no longer associated with
reduced PMD methylation.
Predictors of HMDMethylation
In bivariate analyses, higher placental HMD methylation was
predicted by maternal report of any professional exterminator-
applied pesticides to her lawn or garden before or during preg-
nancy (P¼ 0.01), which became less than a trend after FDR cor-
rection (P¼ 0.11) and was not significantly associated after
adjustment for PMD methylation (Table 3). After adjustment for
PMD methylation, there was a trend for an association between
higher HMD methylation and flea and tick pouch exposure
before or during pregnancy (P¼ 0.07) and FFQ folate in the latter
half of pregnancy (P¼ 0.08, Table 3), but these associations were
not apparent after FDR-correction (Table 3). Pet ownership was
not a significant predictor of HMD methylation (Table 3).
In multivariate models, higher placental HMD methylation
was predicted by maternal report of prenatal exposure to any
professionally applied lawn or garden pesticides before and
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Figure 1: Determination of PMDs, HMDs, and percentage of genome in PMDs. a Individual histograms for 17 MARBLES placenta samples (orange histograms) as well as
three biological replicates of “normal” non-MARBLES placentas (red histograms) with no known pathologies [20]. Methylation data were omitted if a window had fewer
than 20 covered CpG sites. Blue vertical dotted line shows the 60% methylation cutoff between windows with low (PMD) and high (HMD) methylation. “Density” refers
to the density distribution of the genomic windows sampled. b A representative example of individual PMDs and HMDs across chromosome 1, observed as sharp tran-
sitions between methylation states. The position of PMDs and HMDs is consistent between different placental samples, although more variation in percent methyla-
tion is observed over PMDs.
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after FDR correction (P¼ 0.002 and P¼ 0.04, respectively), but not
after adjustment for PMD methylation (Table 2). After adjust-
ment for PMD methylation, indoor pesticides sprayed in the
home any time during pregnancy (reported in regularly col-
lected home walk-through) was associated with a trend towards
lower HMD methylation only prior to FDR correction.
Maternal dietary folate intake in the second half of preg-
nancy was associated with a trend towards higher HMD methyl-
ation in models adjusting only for PMD methylation (P¼ 0.05,
Table 3) and also in multivariate models adjusting for other sig-
nificantly variables selected by AIC (estimate per 100 mg¼ 0.18,
95% CI 0.03, 0.33, P¼ 0.02) in the subset of 20 with food fre-
quency data, prior to but not after FDR corrections (Table 2).
When predictors of HMD methylation were examined sepa-
rately for ASD and TD children, in-home and pet pesticides
were predictors of HMD methylation only in children with ASD,
but lawn and garden pesticides predicted HMD methylation in
both ASD and TD children (Table S4). Child’s birth weight was a
predictor of higher HMD methylation in TD children only. There
was also a trend for associations with lower HMD methylation
by increasing sequencing run, order, and coverage. None of
these associations persisted after FDR-correction.
Predictors of PMD Genomic Coverage
The bimodal pattern of DNA methylation is observed from
analysis of percent methylation over 20-kb windows,
and<60% methylation is used as a determined cut-off for
windows defined as PMDs. In bivariate analyses, prenatal lawn
or garden pesticides were associated with lower PMD genomic
coverage, and maternal smoking history was associated with a
trend towards lower PMD coverage; neither of these associa-
tions was significant after FDR correction (Table S5). In multi-
variate models, identified predictors of the percent of 20-kb
regions with methylation below 60% were similar to those for
average PMD methylation levels, but associations with predic-
tors were in the opposite direction, as expected, including a
negative association with professionally applied lawn or garden
pesticide exposure before or during pregnancy, and positive
associations with non-white race and use of flea and tick
pouches applied to pets before or during pregnancy (Table 2).
Only the negative association with professionally applied lawn
or garden pesticides remained statistically significant after FDR
correction.
Table 1: Bivariate and HMD-adjusted associations between pregnancy exposures and placental PMD methylation
Pregnancy exposure N Frequency
exposed n (%)
Estimate (95% CI) P-value FDR
P-value
Estimate (95% CI)
adjusted for HMD
methylation
P-value FDR
P-value
Own their home 47 28 (59.6) 0.11 (0.42 to 0.20) 0.48 0.99 0.05 (0.29 to 0.2) 0.71 0.99
Maternal education 47
Less than high school 20 (42.6) 0.15 (0.19 to 0.49) 0.37 0.99 0.09 (0.17 to 0.36) 0.48 0.99
Graduate or professional degree 8 (17.0) 0.01 (0.43 to 0.46) 0.95 0.99 0.01 (0.36 to 0.33) 0.94 0.99
Maternal height (m) 47 – 1.04 (3.06 to 0.98) 0.31 0.99 0.53 (2.12 to 1.05) 0.50 0.99
Maternal pre-pregnancy body
mass index
47
Overweight (25 to<30) 14 (29.8) 0.23 (0.14 to 0.60) 0.22 0.98 0.21 (0.06 to 0.49) 0.13 0.89
Obese (30þ) 13 (27.7) 0.15 (0.23 to 0.52) 0.43 0.99 0.11 (0.17 to 0.39) 0.43 0.99
Prenatal vitamin taken Pregnancy
month 1
47 21 (44.7) 0.02 (0.29 to 0.33) 0.89 0.99 0.09 (0.15 to 0.33) 0.45 0.99
Mother ever smoked cigarettes 46 20 (43.5) 0.32 (0.03, 0.60) 0.03 0.39 0.21 (0.02 to 0.44) 0.08 0.99
Parity 47 – 0.05 (0.2, 0.10) 0.53 0.99 0.01 (0.13 to 0.11) 0.90 0.99
Gestational age (weeks) at delivery 47 – 0.07 (0.05 to 0.2) 0.24 0.99 0.02 (0.08 to 0.12) 0.71 0.99
Child birth weight (kg) 39 – 0.01 (0.39 to 0.37) 0.95 0.99 0.14 (0.44 to 0.17) 0.37 0.99
Family owned a cat or dog
during pregnancy
46 25 (54.4) 0.29 (0.58, 0.01) 0.05 0.52 0.26 (0.49, 0.04) 0.02 0.31
Pesticides applied in home
during pregnancy
44 10 (22.7) 0.03 (0.41 to 0.36) 0.89 0.99 0.09 (0.20 to 0.37) 0.54 0.99
Any professionally applied pesticides
sprayed on lawn or garden before or
during pregnancy
45 12 (26.7) 0.45 (0.14, 0.77) 0.01 0.09 0.22 (0.07, 0.51) 0.14 0.91
Used flea pouch products before
or during pregnancy
46 12 (26.1) 0.34 (0.69 to 0.01) 0.05 0.59 0.35 (0.61, 0.09) 0.01 0.13
Used any pet pesticides before
or during pregnancy
45 15 (33.3) 0.26 (0.57 to 0.06) 0.11 0.84 0.25 (0.50, 0.01) 0.04 0.50
Used any indoor pesticides
during pregnancy
47 10 (21.3) 0.05 (0.42 to 0.33) 0.81 0.99 0.07 (0.22, 0.37) 0.63 0.99
Maternal MTHFR677 CT or TT 30 20 (67.7) 0.26 (0.03 to 0.56) 0.08 0.74 0.15 (0.11, 0.41) 0.26 0.99
Food folate (100 mg) from FFQ
FFQ 1 pregnancy weeks 1–20 28 – 0.03 (0.17, 0.22) 0.79 0.99 0.03 (0.13 to 0.18) 0.73 0.99
FFQ 2 pregnancy weeks 21–40 20 – 0.09 (0.28 to 0.1) 0.32 0.99 0.13 (0.25 to 0.00) 0.05 0.55
FFQ 1 if available, if not FFQ 2 33 – 0.02 (0.21 to 0.16) 0.79 0.99 0.01 (0.13, 0.16) 0.85 0.99
Averaged Across FFQ 1 and FFQ 2 33 – 0.09 (0.29, 0.12) 0.39 0.99 0.08 (0.23, 0.08) 0.32 0.99
CI, confidence interval; FFQ, Food Frequency Questionnaire; OR, odds ratio. Bold p-value indicates significance at <0.05; Bold italic p-values are significant at <0.10.
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Predictors of Methylation of Functional Gene Categories
In post-hoc analyses, we examined predictors of average meth-
ylation of three functional categories of regulatory elements
based on placental chromatin state: promoters of active genes
(TSSA), enhancers, and promoters of transcriptionally poised,
bivalent genes (TssBiv) [27]. Active promoter methylation
appeared more sensitive to assay parameters, primarily cover-
age, likely as a result of their small size. In multivariate models
adjusted for coverage, maternal intake of prenatal vitamins in
the first pregnancy month was significantly associated with
increased active promoter methylation, but not after FDR cor-
rections (Table S6). In the subset with food frequency data for
the second half of pregnancy, food folate was associated with
decreased active promoter methylation after adjustment for
prenatal vitamin use in pregnancy month one and coverage.
Average methylation at enhancers tended to be inversely asso-
ciated with pet ownership prior to FDR correction (Table S7).
Maternal MTHFR 677 CT or TT genotype was associated with
increased average enhancer methylation prior to FDR
correction, with and without adjustment for home ownership
and low maternal education. Bivalent promoter methylation
was associated with lawn and garden pesticides before and
after adjustment for several other factors, but not after FDR cor-
rection (Table S8). In the subset with food frequency data for the
second half of pregnancy, food folate was associated with
decreased bivalent promoter methylation in the multivariate
model prior to FDR correction, though the model was unstable
given the small number of participants in this subset and the
high number of variables selected by AIC.
Discussion
We investigated the association between demographic, preg-
nancy, and environmental factors on placental methylation lev-
els. Because placentation occurs early in human development,
alterations in placental methylation levels may therefore reflect
exposure effects on the earliest stages of pregnancy. Overall,
most of the 16 examined pregnancy exposure variables
Table 2: Multivariable models of demographic and environmental predictors of placental methylation
Placental methylation Pregnancy exposure Frequency
exposed n (%)
Estimate (95% CI) P-value FDR
P-value
PMD (n¼44) Lawn/garden pesticidesa 12 (27.3) 0.45 (0.17, 0.72) 0.002 0.03
Pet pesticidesa 15 (34.1) 0.37 (0.61, 0.12) 0.004 0.06
Child non-White race 16 (36.4) 0.32 (0.57, 0.07) 0.01 0.18
PMD in subset with maternal
MTHFR 677 genotype (n¼29)
Maternal MTHFR 677 CT
or TT genotype
20 (69.0) 0.26 (0.05, 0.47) 0.02 0.24
Lawn/garden pesticides a 9 (31.0) 0.24 (0.02, 0.47) 0.04 0.44
Pet flea/tick pouchesa 9 (31.0) 0.37 (0.59, 0.15) 0.002 0.04
Child non-White race 9 (31.0) 0.38 (0.57, 0.19) 0.0004 0.006
Maternal BMI 25þ b 15 (51.7) 0.20 (0.004, 0.40) 0.05 0.59
PMD Adjusted for HMD (n¼ 45) Pet flea/tick pouches a 12 (26.7) 0.36 (0.60, 0.13) 0.003 0.05
Child non-White race 17 (37.8) 0.20 (0.40, 0.10) 0.04 0.50
Mother ever smoked 19 (42.2) 0.19 (0.01, 0.39) 0.06 0.61
HMD methylation – 0.64 (0.42, 0.87) <0.0001 0.002
PMD adjusted for HMD in subset with
maternal MTHFR 677 genotype (n ¼ 26)
Maternal MTHFR 677 CT
or TT genotype
17 (65.4) 0.21 (0.05, 0.38) 0.01 0.20
Pet flea/tick pouches a 8 (30.8) 0.36 (0.56, 0.15) 0.002 0.03
Sprays used in home c 7 (26.9) 0.15 (0.30, 0.002) 0.05 0.58
Child non-White race 8 (30.8) 0.26 (0.43, 0.09) 0.01 0.08
Maternal BMI 25þ b 14 (53.9) 0.27 (0.12, 0.42) 0.001 0.02
HMD methylation – 0.36 (0.23, 0.49) <0.0001 0.002
HMD (n¼45) Lawn/garden pesticides a 12 (26.7) 0.40 (0.16, 0.65) 0.002 0.04
Assay run – 0.11 (0.003, 0.23) 0.06 0.60
Assay order – 0.03 (0.06, 0.004) 0.03 0.34
HMD adjusted for PMD (n¼44) Sprays used in home c 10 (22.7) 0.17 (0.33, 0.001) 0.05 0.56
Assay order – 0.01 (0.01, 0.002) 0.01 0.12
PMD methylation – 0.56 (0.38, 0.74) <0.0001 0.002
HMD adjusted for PMD in Subset
with FFQ data (n¼19)
FFQ dietary folate (100 mg/d)
in late pregnancy
– 0.18 (0.03, 0.33) 0.02 0.28
Pet flea/tick pouches a 7 (36.8) 0.27 (0.69, 0.15) 0.19 0.97
Assay run – 0.23 (0.09, 0.37) 0.004 0.06
Assay order – 0.04 (0.08, 0.01) 0.03 0.38
Assay coverage – 0.28 (0.58, 0.02) 0.06 0.649
PMD Methylation – 0.78 (0.51, 1.04) <0.0001 0.002
Percent 20 kb regions with
methylation < 60% (n¼42)
Lawn/garden pesticidesa 10 (23.8) 0.42 (0.67, 0.17) 0.002 0.03
Pet flea/tick pouchesc 9 (21.4) 0.37 (0.03, 0.70) 0.03 0.42
Sprays used in home c 10 (23.8) 0.30 (0.01, 0.58) 0.04 0.44
Non-White race 15 (35.7) 0.33 (0.07, 0.58) 0.01 0.19
aIncludes exposure occurring in the 6-months before pregnancy.
bPre-pregnancy body mass index of 25 or more (overweight or obese).
cExposure occurring during pregnancy. Bold p-value indicates significance at <0.05; Bold italic p-values are significant at <0.10.
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examined were not predictive of average placental PMD or HMD
methylation or the genomic proportion of PMDs. There were
associations between methylation and dietary folate and
MTHFR677 CT or TT (less efficient folate metabolizing) geno-
types in the subsets with these data, but these findings were
not consistent and were relatively unstable. Self-reported expo-
sure during pregnancy to various types of pesticides, especially
sprays and foggers professionally applied to lawns and gardens
and those applied to control fleas and ticks on pets, were the
most significant predictors of each type of methylation meas-
ure. These associations between pesticide exposures and pla-
cental methylation varied in direction across pesticide
application types. This could suggest that each pesticide appli-
cation type has differential effects on methylation, or this could
be taken as evidence of chance findings with many compari-
sons within a relatively small sample, despite correction for
multiple comparisons.
The negative association between PMD methylation and pet
or flea/tick pesticides was attenuated to non-significance after
FDR correction with adjustment for pet ownership. This sug-
gests that there are epigenetic changes associated with having
a pet that partially explained the association with pet pesti-
cides, and is consistent with the inverse correlation of pet
ownership with enhancer methylation we observed prior to FDR
correction. These results are biologically plausible given known
associations between early life exposure to pets in the home
and other health-relevant adaptations, including development
of more diverse infant fecal microbial composition [28], differ-
ences in innate [29], and adaptive [30] immune systems, and
fewer atopic diseases in the child [31–33]. It is also possible this
observed association could have been a chance finding as a
result of multiple comparisons that was lost after adjustment.
Lawn and garden pesticides tended to be robustly associated
with higher placenta PMD methylation in children with both
ASD and TD. Though maternal report of pesticide exposures
was obtained prospectively, has been shown to be highly reli-
able [34], and correlates with measured pesticide exposures
found in dust samples [35], inaccuracies in maternal reported
pesticide exposure could have attenuated associations. Further,
because these factors were examined in relation to the percent
methylation averaged across PMDs/HMDs throughout the
genome, effects at individual domains or genes could have been
diluted. However, the additional positive association observed
with lawn and garden pesticides and methylation over poised,
bivalent promoters after multiple adjustments further suggests
the meaningful association of these results.
Table 3: Bivariate and PMD-adjusted associations between pregnancy exposures and placental HMD methylation
Pregnancy exposure N Frequency
exposed n (%)
Estimate (95% CI) P-value FDR
P-value
Estimate (95% CI)
adjusted for PMD
methylation
P-value FDR
P-value
Own their home 47 28 (59.6) 0.09 (0.35, 0.18) 0.52 0.99 0.03 (0.23, 0.18) 0.80 0.99
Maternal education 47
Less than high school 20 (42.6) 0.08 (0.21, 0.37) 0.58 0.99 0.00 (0.23, 0.22) 0.97 0.99
Graduate or professional degree 8 (17.0) 0.04 (0.35, 0.42) 0.85 0.99 0.03 (0.27, 0.33) 0.85 0.99
Maternal height (m) 47 – 0.68 (2.40, 1.05) 0.43 0.99 0.11 (1.47, 1.25) 0.87 0.99
Maternal pre-pregnancy body
mass index
47
Overweight (25 to<30) 14 (29.8) 0.02 (0.30, 0.35) 0.90 0.99 0.11 (0.36, 0.13) 0.36 0.99
Obese (30þ) 13 (27.7) 0.05 (0.28, 0.38) 0.77 0.99 0.04 (0.29, 0.21) 0.75 0.99
Prenatal vitamin taken pregnancy
month 1
47 21 (44.7) 0.09 (0.35, 0.17) 0.49 0.99 0.10 (0.30, 0.10) 0.31 0.99
Mother ever smoked cigarettes 46 20 (43.5) 0.16 (0.10, 0.42) 0.23 0.98 0.02 (0.24, 0.21) 0.89 0.99
Parity 47 – 0.05 (0.18, 0.08) 0.41 0.99 0.03 (0.13, 0.07) 0.59 0.99
Gestational age (weeks) at delivery 47 – 0.07 (0.03, 0.18) 0.17 0.95 0.03 (0.05, 0.12) 0.42 0.99
Child birth weight (kg) 39 – 0.15 (0.13, 0.44) 0.29 0.99 0.16 (0.07, 0.39) 0.17 0.95
Family owned a cat or dog
during pregnancy
46 25 (54.4) 0.05 (0.31, 0.22) 0.73 0.99 0.13 (0.09, 0.43) 0.24 0.99
Professionally applied pesticides
sprayed in home during pregnancy
44 10 (22.7) 0.13 (0.43, 0.18) 0.41 0.99 0.11 (0.33, 0.11) 0.31 0.99
Any professionally applied pesticides
sprayed on lawn or garden before
or during pregnancy
45 12 (26.7) 0.39 (0.11, 0.66) 0.01 0.11 0.17 (0.09, 0.43) 0.19 0.97
Used flea pouch products before or
during pregnancy
46 12 (26.1) 0.02 (0.29, 0.32) 0.92 0.99 0.22 (0.02, 0.46) 0.07 0.69
Used any pet pesticides before or
during pregnancy
45 15 (33.3) 0.01 (0.29, 0.28) 0.97 0.99 0.14 (0.08, 0.37) 0.21 0.98
Used any indoor pesticides
during pregnancy
47 10 (21.3) 0.15 (0.47, 0.17) 0.34 0.99 0.13 (0.37, 0.12) 0.31 0.99
Maternal MTHFR677 CT or TT 30 20 (67.7) 0.26 (0.11, 0.62) 0.16 0.94 0.08 (0.25, 0.40) 0.63 0.99
Food folate (100 mg) from FFQ
FFQ 1 pregnancy weeks 1–20 28 – 0.00 (0.16, 0.16) 0.99 0.99 0.01 (0.14, 0.11) 0.83 0.99
FFQ 2 pregnancy weeks 21–40 20 – 0.04 (0.14, 0.23) 0.63 0.99 0.12 (0.01, 0.24) 0.08 0.71
FFQ 1 if available, if not FFQ 2 33 – 0.05 (0.20, 0.11) 0.54 0.99 0.03 (0.15, 0.08) 0.56 0.99
Averaged across FFQ 1 and FFQ 2 33 – 0.01 (0.19, 0.16) 0.88 0.99 0.04 (0.10, 0.17) 0.58 0.99
CI, confidence interval; FFQ, Food Frequency Questionnaire; OR, odds ratio. Bold p-value indicates significance at <0.05; Bold italic p-values are significant at <0.10.
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Another potential limitation of this study was that the heter-
ogeneity of placenta samples might have obscured inter-
individual differences, despite efforts to collect samples from a
uniform manner and location. The samples analyzed were a
heterogeneous mixture of cell types, including trophoblasts,
mesenchymal stromal cells, and fetal vascular and hemato-
poetic cells. However, we previously observed no detectable dif-
ferences in large scale methylation levels between human
placentas isolated from 10 different regions (including the
maternal and fetal side) [20] or between rhesus trophoblast
compared with rhesus placenta [19]. Therefore, at least for pla-
centa, cell type and regional differences are unlikely to be a
major factor for large-scale methylation levels observed in this
study.
Finally, pesticide classes with differential mechanisms of
action were not distinguished in this study; future studies
should more carefully examine specific pesticide classes in rela-
tion to DNA methylation to determine which have the strongest
associations. The majority of pesticides used in the reported
household products are pyrethroids since the ban of organo-
phosphate pesticides [36–38]. The associations with pet pesti-
cides were attenuated, but still present when restricted to pet
owners. The strongest and most robust finding was for an asso-
ciation between sprays and foggers professionally applied out-
side the home and higher average methylation within PMDs
and a reduced proportion of the genome in PMDs. Formulations
for pesticides used outdoors in professional lawn and garden
applications (e.g., Bifenthrin) are typically designed to be more
stable in sunlight and degrade less rapidly [39]; they also show
greater neurotoxicity [40, 41]). The association between these
outdoor pesticides and differential DNA methylation is congru-
ent with other evidence for in vitro [42] and in vivo [43–45]) effects
of pesticides on DNA methylation.
What biological insights can we infer from these large-scale
genome-wide methylation differences associated with pesti-
cides? Because DNA methylation patterns, including those of
PMDs and HMDs, mirror the transcriptional patterns in placenta
and pre-implantation embryos [19], gene expression changes
induced by pesticides could be reflected in the levels of placen-
tal methylation. Since PMDs reflect genes that are inactive tran-
scriptionally, but environmentally responsive, they may reflect
a type of chromatin “storage boxes” within the genome in early
life [46]. Differences in the average PMD methylation levels
genome-wide may reflect the extent to which these “storage
box genes” were transcribed or utilized in utero. For instance,
both PMD and related poised, bivalent promoter methylation
[20] were associated with lawn or garden pesticide use, suggest-
ing past transcriptional differences in placenta associated with
pesticide exposure. Though average PMD or HMD methylation
levels were not associated with ASD in this study, it is possible
that global changes across PMDs/HMDs linked to exposures are
associated with more specific methylation changes that influ-
ence ASD risk in a subset. Further, perhaps these methylation
changes alone are not enough to induce ASD, but are but one hit
in a multi-hit process. Finally, these exposure markers could be
associated with adverse outcomes other than ASD. These find-
ings should be explored further in larger studies with bio-
markers for pesticide exposures.
This study provides some of the first evidence on pregnancy
and environmental factors that could influence DNA methyla-
tion in placental tissue of children at high risk for ASD. We
found consistent associations of maternal PMD and HMD pla-
cental DNA methylation with outdoor pesticides, suggesting a
possible mechanism by which pesticide exposures in prenatal
life could alter gene expression and its sequelae. Larger studies
using more detailed measures and biomarkers of pesticide
exposure should attempt to confirm these associations. More
generally, MethylC-seq analyses of human placenta samples
could be useful in future prospective studies for the detection of
exposure relevant methylation biomarkers.
Methods
MARBLES Study and Sample Selection
Placenta tissues were obtained as previously described [47]
from the MARBLES (Markers of Autism Risk in Babies: Learning
Early Signs) study, a prospective study of the environmental,
genetic, and epigenetic factors leading to autism. Parents were
enrolled that already had a child with autism and were preg-
nant or planning another pregnancy. The younger sibling from
this pregnancy was at significantly (13-fold) higher risk of hav-
ing autism than children in the general population [10].
MARBLES recruited families from Northern California from lists
of children receiving services through the California
Department of Developmental Services, from other studies at
the MIND Institute, and by self-referral. Inclusion criteria for the
MARBLES Study included: (i) maternal age at least 18 years; (ii)
planning a pregnancy or pregnant; (iii) one or both parents of
the current or planned pregnancy being the biological parent of
a child with ASD; and (iv) residence within the specified catch-
ment area in California; (v) English-speaking. Proband ASD sta-
tus was confirmed and mothers were seen at regular intervals
during pregnancy with biosample collection starting at enroll-
ment and continuing at each visit. The placenta, cord blood,
and other samples were collected and frozen at birth and the
children were followed until a diagnosis of autism or TD was
obtained at age 36 months by ADI-R in addition to other assess-
ments. Once placentas were obtained shortly after birth, they
were chilled, transported to a central lab and maintained until
processing, with a time interval between birth and processing of
1–24 h. 3  3 cm full thickness samples were taken from a uni-
form location mid-way between the cord insertion and periph-
ery, assigned sample identifiers, and were stored frozen at
80C. For the purposes of this investigation, placenta speci-
mens were removed from the freezer and, while still frozen, ali-
quots were taken from the fetal surface just beneath the
chorioamniotic membranes, moved to a separate container and
refrozen. Batched aliquots were thawed, whole aliquot speci-
mens were homogenized, and DNA was isolated using Qiagen’s
Puregene kit from MARBLES placenta samples from full-term
pregnancies of 24 children who received a final 36-month clini-
cal diagnosis of ASD by 29 September 2014 and 23 typically
developing children matched to the children with ASD by gen-
der and birth year (within 1.5 years), with preference given to
those with greater availability of other study data. Due to the
naturally occurring high proportion of males to females with
autism, seen also in the MARBLES study, only two each of the
autism and typical placentas were derived from births of female
neonates. All participants gave written informed consent for
data and sample use and protocols were approved by UC Davis
IRB.
Diagnostic Classification
Children’s development was assessed by trained and reliable
examiners with final diagnostic assessments at 36 months. All
children are assessed for autism symptoms using the gold
Schmidt et al. | 7
standard Autism Diagnostic Observation Schedule-Generic
(ADOS) ([48, 49]). A best estimate clinical diagnosis (BECD) was
given through consensus of two clinicians based on DSM-IV or
DSM-5 criteria. Placenta samples were categorized based on
whether the child met ADOS and DSM criteria for ASD, showed
TD, or had impairments in some domains, but did not meet the
full ASD diagnostic criteria (other developmental concerns).
MethylC-seq
Placenta samples were frozen immediately after birth. As previ-
ously described [20], 5-lg placental DNA was extracted, soni-
cated to 300 bp, and methylated Illumina adapters were
ligated to the ends using NEB’s NEBNext DNA library prep kit.
The library was bisulfite converted using Zymo’s EZ DNA
Methylation-Lightning Kit, amplified for 14 cycles using
PfuTurbo Cx, purified with Agencourt AMPure XP beads, and
sequenced on an Illumina HiSeq 2000. Laboratory personnel
were blinded to the case status of the samples, and samples
were arranged randomly. Reads were mapped to the hg19 ver-
sion of the human genome using BS Seeker [50]. To prevent clo-
nal PCR amplification biases, only one read out of those with
identical genomic positions was kept. CpG site methylation
data were combined from both DNA strands. Sequencing infor-
mation for each placenta sample, including the total reads, total
mapped reads, coverage, and conversion efficiency is provided
in Table S9.
Defining PMDs/HMDs
PMDs and HMDs were defined as previously described [20]. In
brief, methylation data from 17 typical placentas were com-
bined to create a single, high-coverage map of methylation
across the genome (as in Fig. 1). In tracks of percent methylation
in the UCSC Genome Browser and placental tracks available
through the public track hub, “UCD Methylation” (http://
genome.ucsc.edu), PMDs and HMDs can be detected visually as
large domains of lower levels of DNA methylation. Visually
annotated PMD and HMD portions of this consensus genome
were used to train a two-state hidden Markov model (HMM) to
differentiate PMDs and HMDs using StochHMM [20, 51]. The
model was then applied to the same high-coverage methylation
data to define the boundaries of PMD/HMDs in typical placen-
tas. Those boundary coordinates were used for calculating aver-
age percent methylation over all PMDs and all HMDs in each
MARBLES placenta sample.
Defining Enhancers, Active Promoters, and Poised
Promoters from Chromatin State Maps
Previously described chromatin state HMM analysis in placenta
(ChromHMM) [27] were used to define active promoters
(ChromHMM state 1, TssA, defined by H3K4me3), enhancers
(ChromHMM state 7, Enh, defined by H3K4me1), and bivalent
promoters (ChromHMM state 10, defined by H3K4me3 and
H3K27me3). For each of these placental ChromHMM states, per-
cent methylation was calculated for each instance of that state
in the genome by averaging over the CpG sites in the element
and then averaging over all the element of that state in the
genome. Mean percent methylation of ChromHMM-defined
states is shown for ASD and TD placenta samples in Table S10.
Statistical Analyses for Associations between
Methylation and Demographic Characteristics and
Environmental Exposures
Information on demographic factors, environmental exposures,
nutritional supplement use, and medical history were prospec-
tively collected through telephone-assisted interviews, mailed
questionnaires, and medical record abstraction. The following
variables were analyzed for associations with PMD total average
methylation, HMD total average methylation, and the percent
of the 20-kb windows with methylation below 60%: sequencing
run, order, and coverage; child race (white non-Hispanic [refer-
ence], Asian, multi-racial, white Hispanic, non-white Hispanic);
child sex (male [reference]/female); maternal pre-pregnancy
body mass index (BMI) (categorized as<25 [reference], 25 to <30
[overweight], and 30þ [obese]), home ownership (yes/no [refer-
ence]); whether the mother ever smoked in her lifetime (yes/no
[reference]); maternal education (no college degree, college
4-year degree [reference], graduate or professional degree); ges-
tational age of child (in days); parity (one previous live birth is
reference); maternal height; child birthweight (grams); profes-
sionally applied pesticides to lawn or garden 6 months before
pregnancy through the end of pregnancy (yes, no [reference]);
professionally applied pesticides to inside of home before or
during pregnancy (yes, no [reference]; flea/tick pouches applied
to pet, flea/tick collars, or flea/tick pet soaps or shampoos before
or during pregnancy (yes, no [reference]). Many exposure cate-
gories were collapsed for inclusion in multivariate models as
appropriate based on bivariate effect estimates and AIC.
Because only one mother had underweight pre-pregnancy BMI
(<18.5) or reported smoking during pregnancy, and none
reported not taking a prenatal vitamin at any time during preg-
nancy, we were unable to evaluate these exposures in relation
to methylation. Maternal MTHFR 677 genotype from Taqman
assays in maternal blood DNA and dietary folate equivalents
calculated from Block food frequencies completed by mothers
for the first half and second half of pregnancy were also exam-
ined in bivariate analyses (Tables 1, 3, S2). Because these data
were only available for a subset of those with methylation,
these variables were not considered in multivariate model
selection, but if they were significant at<30% then they were
examined in separate adjusted models (Table 2).
We first performed bivariate linear regression using SAS
software version 9.4 for each exposure in relation to PMD meth-
ylation and separately to HMD methylation (Tables 1, 3, S2). To
facilitate interpretation of regression coefficients, PMD and
HMD methylation was expressed in 5 percentage point and 2
percentage point units, respectively, so that coefficients (and
effect size estimates based on them) correspond to an approxi-
mately 2 SD change in the dependent variable. Each exposure
that was associated with methylation at P< 0.30 in the bivariate
analysis was then retained in a full multivariate model.
Subsequently we used Akaike information criterion (AIC) to
select the model that balances best fit and parsimony among
candidate models [52, 53]. To produce our final models, we used
sandwich estimators to produce homoscadisticity-robust esti-
mates of the 95% confidence interval given that the conditional
variance of outcomes appeared to vary with the regression-
based predicted values. We assessed predictors of PMD methyl-
ation, PMD methylation adjusted for HMD methylation, HMD
methylation, HMD methylation adjusted for PMD methylation
and the percent of the 20-kb windows with methylation below
60% [using a 6% (2 SD) change as the unit]. To account for the
multiplicity of hypotheses being assessed, we adjusted the
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P-values to control the FDR at 5% [54]. Once significant factors
were identified, diagnostic status was added to the model to
examine the adjusted association between ASD and methyla-
tion. In post-hoc analyses, predictors of average methylation
across other functional categories were also examined, includ-
ing: promotors of active genes, enhancers, and promoters of
transcriptionally poised, bivalent genes.
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